# Medtronic Plc

Type: Company (MDT)

Source: GetYourBrief — https://getyourbrief.com/entity/medtronic-plc
Canonical HTML page: https://getyourbrief.com/entity/medtronic-plc

## Timeline

- **2026-07-17**: MOU Signed & ICU Inaugurated — Medtronic and Apollo Hospitals formally signed a strategic partnership agreement and inaugurated the 11-bed advanced ICU at Apollo Hospitals, Jubilee Hills, Hyderabad. The unit is fully operational with Medtronic's ACM technologies.
- **2026-03-06**: Market Debut — MiniMed begins trading as an independent entity on the US exchange.
- **2026-03-06**: IPO Pricing — MiniMed prices 28 million shares at $20.00 per share, raising $560 million.
- **2026-03-05**: Pricing Finalized — The IPO prices at $560 million, falling below the initially marketed price range.
- **2026-03-04**: Analyst Debate — Market analysts debate the valuation of the diabetes unit amid competitive pressures.
- **2026-02-24**: Initial Filing — Medtronic's diabetes unit MiniMed seeks up to $784 million in U.S. IPO.
- **2026-02-10**: IPO Filing — MiniMed Group Inc. files S-1 registration statement for a US initial public offering.
- **2025-10-15**: Strategic Review — Medtronic announces intent to spin off its diabetes business unit to focus on core medtech.

## Recent coverage (5 stories, network-wide)

### Apollo Hospitals' 11-Bed Smart ICU Puts Medtronic Tech at the Bedside
2026-07-24 22:21:15 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 1

Apollo Hospitals deploys an 11-bed ICU fully integrated with Medtronic's acute care monitoring technologies at its Jubilee Hills campus. The initiative aims to enhance clinical workflow, improve patient outcomes, and demonstrate how technology-led critical care can set new benchmarks for Indian hospitals.
Full story: https://gethealthbrief.com/story/apollo-medtronic-icu-health-it

### Medtronic-Apollo 11-Bed Smart ICU Targets Real-World Evidence for Medtech R&D
2026-07-24 22:21:07 · Sector: bio · Sentiment: Positive · Impact: 6/10 · Sources: 1

Medtronic and Apollo Hospitals join forces to deploy an 11-bed advanced ICU in Hyderabad, aiming to harness real-world clinical data that can refine monitoring technologies. The collaboration could accelerate regulatory strategies and set a precedent for co-development between medtech and healthcare providers.
Full story: https://getbiobrief.com/story/medtronic-apollo-icu-future-hyderabad-bio

### Medtronic’s MiniMed Prices $560 Million IPO at $20 Per Share
2026-03-06 03:37:58 · Sector: finance · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Medtronic plc has priced the initial public offering of its diabetes-focused subsidiary, MiniMed Group Inc., at $20.00 per share for 28 million shares. The $560 million carve-out aims to provide the specialized unit with independent capital to compete in the high-growth insulin delivery and monitoring market.
Full story: https://getfinancebrief.com/story/medtronic-minimed-ipo-pricing-analysis

### Medtronic’s MiniMed Prices IPO at $20 Per Share, Raising $560 Million
2026-03-06 03:34:10 · Sector: bio · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Medtronic’s diabetes subsidiary, MiniMed Group Inc., has priced its initial public offering at $20.00 per share, successfully raising $560 million. The offering of 28 million shares comes in below initial valuation targets but marks a significant strategic pivot for parent company Medtronic plc.
Full story: https://getbiobrief.com/story/medtronic-minimed-ipo-pricing-analysis

### Medtronic Unit MiniMed Raises $560M in IPO Amid Cautious Market Pricing
2026-03-06 03:10:32 · Sector: bio · Sentiment: Positive · Impact: 7/10 · Sources: 2

Medtronic has successfully spun off its diabetes management business, MiniMed Group Inc., raising $560 million in a US IPO. Despite the significant capital raise, the offering priced below the initial marketed range, reflecting investor scrutiny of the competitive diabetes technology landscape.
Full story: https://getbiobrief.com/story/medtronic-minimed-ipo-diabetes-spin-off

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.